| MSD Merck Sharp & Dohme AG - Zinplava, Konzentrat zur Herstellung einer Infusionslösung |
| 66344 | | 01 | | Zinplava | | Konzentrat zur Herstellung einer Infusionslösung | | J06BB21 | | Bezlotoxumab | | 20.11.2017 | | |
|
| Composition |
| bezlotoxumabum 25 mg, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, polysorbatum 80, acidum penteticum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Bezlotoxumabum | 25 mg/ml |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Acidum Penteticum | | Sodium Chloride | | Natrii Citras Dihydricus | | Polysorbatum 80 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | Yes |
|
